Skip to main content
OpenTrials
Completed

NCT Number: NCT03424785

Long Term Clinical Implications in Chinese Patients With Aortic Intramural Hematoma

The study evaluates outcomes of intramural hematomas after long-term follow up and establish predictive factors in Chinese population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Aortic Intramural Hematoma Acute Aortic Syndrome Aortic Diseases Cardiovascular Diseases Hematoma Hemorrhage Pathologic Processes Pathological Conditions, Signs and Symptoms Vascular Diseases

Age range

30 year–87 year

Sex eligibility

All sexes

Study type

Observational

About this study

270 intramural hematoma patients with clinical and imaging follow up were retrospectively studied in present study. The primary endpoint was consisted of aortic disease-related death, aortic dissection, penetrating atherosclerotic aortic ulcer , thickening of aorta hematoma and aortic complications requiring surgical or endovascular treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Type A aortic hematoma
  • Type B aortic hematoma

Exclusion criteria

  • Aortic without initial intimal flap formation.

Treatment and study plan

drug, stent, surgical treatment

Other

drug, stent, surgical treatment

Primary outcomes

  1. hematoma thickness and a baseline MAD

    Time frame: 14years

    Medication and short-term imaging are recommended for Chinese IMH patients with a hematoma thickness less than 10.45 mm and a baseline MAD less than 44.75 mm. Rigorous medical observation should also be performed during the acute phase of IMH.

Sponsors and collaborators

Lead sponsor

Shenyang Northern Hospital

Other

Registry information

Official study title

Long Term Follow-up and Clinical Implications in Chinese Patients With Aortic Intramural Hematoma

Important dates

Study start
2008
Primary completion
2017
Study completion
2017
First posted
Feb 7, 2018
Registry last updated
Feb 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.